The civic record
Read. Follow. Verify.Michigan Bill Requires Health Insurers to Cover Menopause Treatments and Ban Prior Authorizations
Last action · December 2, 2025: REFERRED TO COMMITTEE ON HEALTH POLICYSponsors: Rosemary Bayer and 2 others
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Would Do
Health insurance policies issued or renewed in Michigan must cover medically necessary menopause and perimenopause care, including hormone replacement therapy, and insurers are prohibited from requiring or step therapy for those hormone treatments.
- Senate Bill 718 was introduced in the Michigan Senate during the 2025-2026 legislative session and referred to the Committee on Health Policy. context
- The Insurance Code of 1956 governs the regulation of insurance policies and insurers operating within the state of Michigan. context
Who It Would Affect
Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.
Health insurance policyholders
Insured individuals receiving menopause and perimenopause care gain guaranteed insurance coverage and relief from prior authorization requirements for hormone replacement therapy.
Health insurers
Insurers must update their coverage policies to include menopause and perimenopause care and must eliminate pre-approval and step therapy requirements for hormone replacement medications.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
What specific treatments for menopause must health insurers cover?
Can health insurance companies require prior approval before prescribing hormone replacement therapy?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Currently in committee. The next step in the legislative lifecycle is Floor Vote.
Procedural history
2 actions- Dec 2, 2025SenateCommitteeREFERRED TO COMMITTEE ON HEALTH POLICY
- Dec 2, 2025SenateIntroducedINTRODUCED BY SENATOR ROSEMARY BAYER
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Banning Prior Authorization for Specific Hormone Therapies
The legislation removes administrative approval barriers specifically for hormone replacement therapy used for menopause and perimenopause, marking a direct statutory limit on insurer utilization management protocols.
Connected Entities
Sources
legislature.mi.gov
Analysis Score
0–100- Significance65How much this matters to a regular citizen
- Controversy40Intensity of disagreement among stakeholders
- Entertainment10Compellingness for a non-policy-wonk reader
- Buzz30Current news / social attention level
Publisher tools